The reported frequencies of mutations in cutaneous melanoma are 37–60% in BRAF [15,16], 13–25% in NRAS, 12% in NF1, 6–7% in MAP2K1, and 2–8% in KIT [4,16]. This evidence concerns the gene MAP2K1 and cutaneous melanoma.